- ISIN
- CA02074J5017
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Nov 12, 2024
Highlights
- Market Cap
- $133.31M
- Enterprise Value
- $79.06M
- EPS (TTM)
- -$0.97
- Total Revenue (TTM)
- $10.83M
- Gross Profit (TTM)
- $9.39M
- EBITDA (TTM)
- -$27.04M
- Year Range
- $4.50 - $11.54
- Target Price
- $14.00
- ROA (TTM)
- -26.95%
- ROE (TTM)
- -32.48%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ACOG Performance Chart
Alpha Cognition Inc (ACOG) is down 6.5% since the beginning of the year. At $6 per share, ACOG is trading 47.3% below its 52-week high of $12.
Loading charts...
Returns By Period
Alpha Cognition Inc (ACOG) has returned -6.46% so far this year and -37.90% over the past 12 months.
Alpha Cognition Inc
- 1D
- -1.62%
- 1M
- 0.50%
- YTD
- -6.46%
- 6M
- 4.65%
- 1Y
- -37.90%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
ACOG Monthly Returns History
Based on dividend-adjusted daily data since Nov 12, 2024, ACOG's average daily return is +0.14%, while the average monthly return is +1.88%. At this rate, an investment would double in approximately 3.1 years.
Historically, 45% of months were positive and 55% were negative. The best month was May 2025 with a return of +69.0%, while the worst month was Jan 2026 at -25.5%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 5 months.
On a daily basis, ACOG closed higher 46% of trading days. The best single day was May 16, 2025 with a return of +27.0%, while the worst single day was Aug 14, 2025 at -19.9%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -25.54% | 23.97% | -8.50% | 8.74% | 3.69% | -1.78% | -6.46% | ||||||
| 2025 | -2.89% | 5.07% | -15.81% | 9.09% | 69.02% | 0.00% | -2.36% | -8.89% | -21.57% | -4.92% | -2.75% | 7.97% | 10.36% |
| 2024 | 16.14% | -11.03% | 3.33% |
Benchmark Metrics
Alpha Cognition Inc has an annualized alpha of 19.53%, beta of 1.02, and R2 of 0.05 versus S&P 500 Index. Calculated based on daily prices since November 13, 2024.
- This stock captured 6.56% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -21.93%) - a profile typical of hedging or uncorrelated assets.
- R2 of 0.05 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 19.53%
- Beta
- 1.02
- R²
- 0.05
- Upside Capture
- 6.56%
- Downside Capture
- -21.93%
Return for Risk
Risk / Return Rank
ACOG ranks 20 for risk / return — below 20% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Alpha Cognition Inc (ACOG) and compare them to S&P 500 Index.
| ACOG | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.79 | ||
| Sortino ratioReturn per unit of downside risk | -3.57 | ||
| Omega ratioGain probability vs. loss probability | 0.94 | 1.41 | -0.46 |
| Calmar ratioReturn relative to maximum drawdown | -0.63 | 2.93 | -3.56 |
| Martin ratioReturn relative to average drawdown | -0.96 | 13.52 | -14.48 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Alpha Cognition Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Alpha Cognition Inc was 59.96%, occurring on Feb 5, 2026. The portfolio has not yet recovered.
The current Alpha Cognition Inc drawdown is 45.91%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -59.96%Feb 2026 | 7mo 2d | — | 11mo 1dJul 2025 - now |
2025 selloff2025 | -43.78%Apr 2025 | 4mo 10d | 27d | 5mo 7dNov 2024 - May 2025 |
2025 selloff2025 | -20.28%May 2025 | 7d | 1mo 5d | 1mo 12dMay 2025 - Jul 2025 |
2025 selloff2025 | -9.08%May 2025 | 7d | 1d | 8dMay 2025 - May 2025 |
2024 pullback2024 | -6.45%Nov 2024 | 1d | 5d | 6dNov 2024 - Nov 2024 |
Drawdown Indicators
| ACOG | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -59.96% | -56.78% | -3.18% |
Max Drawdown (1Y)Largest decline over 1 year | -59.96% | -9.10% | -50.86% |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -45.91% | -0.74% | -45.17% |
Average DrawdownAverage peak-to-trough decline | -28.68% | -10.72% | -17.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 39.48% | 1.97% | +37.51% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Alpha Cognition Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Alpha Cognition Inc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ACOG relative to other companies in the Biotechnology industry. Currently, ACOG has a P/S ratio of 10.8. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ACOG in comparison with other companies in the Biotechnology industry. Currently, ACOG has a P/B value of 2.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with ACOG
Add Alpha Cognition Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ACOG